Penn Advances the Treatment and Prevention of Hepatitis B and C

More than 4 million people in the United States are infected with hepatitis C and about 1.5 million people nationwide are infected with chronic hepatitis B. Hepatitis B and C are silent diseases, meaning they are difficult to detect because patients are often asymptomatic. Although hepatitis is curable, untreated hepatitis is a significant risk factor for liver cancer.

Screening and maintaining healthy lifestyle practices are key for prevention of hepatitis B and C. Rajender Reddy, MD, director of hepatology and medical director of the liver transplantation program at the Hospital of the University of Pennsylvania says: "Penn Medicine is at the cutting edge of research and development of new forms of therapy for treatment of hepatitis B and C."

Penn Gastroenterology is currently involved in 15 research studies and recently added four new hepatologists to the staff.

Penn Gastroenterology        Hepatitis B        Hepatitis C 

Pennsylvania Hospital's Pavilion Now Open

Pennsylvania Hospital is pleased to announce the opening of the Pavilion, a deluxe 8-bed inpatient unit offering private rooms. Amenities include fine linens, gourmet meals, and concierge service. Adjoining suites are available to accommodate family members if desired.

Pavilion Website         Pavilion Items Available at the Shop at Penn Med

A Program for Older Adults with Cancer

Cancer affects older adults more than any other age group. Older patients face different challenges than younger patients. They may have medical or social issues that complicate their care, such as living alone, having other medical conditions, or living on a fixed income. The Joan Karnell Cancer Center at Pennsylvania Hospital recognizes that older adults with cancer may require specialized care to support themselves and their families.

Geriatric Oncology        Joan Karnell Cancer Center        Supportive Care

subscriber information	click here to UNSUBSCRIBE